Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Individualized P2Y12 Receptor Antagonists Treatment Based on Agregometry Versus Fixed Dose Regimen in Patients After Acute Myocardial Infarction

NCT04369534 is registered in ClinicalTrials.gov with University of Zagreb as lead sponsor.

NCT NCT04369534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04369534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Individualized P2Y12 Receptor Antagonists Treatment Based on Agregometry Versus Fixed Dose Regimen in Patients After Acute Myocardial Infarction
Lead sponsor
University of Zagreb
Phase
Phase 4
Overall status
Completed
Start date
December 1, 2015
Completion date
December 1, 2019
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, individualized therapy, nstemi - non-st segment elevation mi, platelet aggregation, stemi